419 related articles for article (PubMed ID: 16961428)
21. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
[TBL] [Abstract][Full Text] [Related]
22. Guanfacine extended release: a novel treatment for attention-deficit/hyperactivity disorder in children and adolescents.
Faraone SV; McBurnett K; Sallee FR; Steeber J; López FA
Clin Ther; 2013 Nov; 35(11):1778-93. PubMed ID: 24139092
[TBL] [Abstract][Full Text] [Related]
23. New options in the pharmacological management of attention-deficit/hyperactivity disorder.
Olfson M
Am J Manag Care; 2004 Jul; 10(4 Suppl):S117-24. PubMed ID: 15352538
[TBL] [Abstract][Full Text] [Related]
24. Improving decision making in the treatment of ADHD.
Vitiello B
Am J Psychiatry; 2008 Jun; 165(6):666-7. PubMed ID: 18519529
[No Abstract] [Full Text] [Related]
25. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
Findling RL
Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
[TBL] [Abstract][Full Text] [Related]
26. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
27. In the pipeline: non-stimulant ADHD meds.
Glazer WM
Behav Healthc; 2010 Jan; 30(1):30-1. PubMed ID: 20184258
[No Abstract] [Full Text] [Related]
28. Innovations and recent trends in the treatment of ADHD.
Madaan V; Kinnan S; Daughton J; Kratochvil CJ
Expert Rev Neurother; 2006 Sep; 6(9):1375-85. PubMed ID: 17009924
[TBL] [Abstract][Full Text] [Related]
29. Long-term outcomes with medications for attention-deficit hyperactivity disorder: current status of knowledge.
Huang YS; Tsai MH
CNS Drugs; 2011 Jul; 25(7):539-54. PubMed ID: 21699268
[TBL] [Abstract][Full Text] [Related]
30. The potential for misuse and abuse of medications in ADHD: a review.
Clemow DB; Walker DJ
Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological management of a youth with ADHD and a seizure disorder.
Gonzalez-Heydrich J; Weiss M; Connolly M; Wambera K; Jan JE; Plioplys S; Dunn DW; Kratochvil CJ
J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1527-32. PubMed ID: 17135999
[No Abstract] [Full Text] [Related]
32. Combination therapy patterns and predictors of ADHD in commercially insured and Medicaid populations.
Molife C; Bernauer MJ; Farr AM; Haynes VS; Kelsey D
Postgrad Med; 2012 Sep; 124(5):7-22. PubMed ID: 23095422
[TBL] [Abstract][Full Text] [Related]
33. Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006.
Harpin VA
Arch Dis Child Educ Pract Ed; 2008 Apr; 93(2):58-65. PubMed ID: 18356307
[TBL] [Abstract][Full Text] [Related]
34. Pharmacologic alternatives to psychostimulants for the treatment of attention-deficit/hyperactivity disorder.
Popper CW
Child Adolesc Psychiatr Clin N Am; 2000 Jul; 9(3):605-46, viii. PubMed ID: 10944659
[TBL] [Abstract][Full Text] [Related]
35. Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments.
Prince JB
Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):13-50. PubMed ID: 16321724
[TBL] [Abstract][Full Text] [Related]
36. Pharmacology and pharmacogenetics of pediatric ADHD with associated aggression: a review.
Patel BD; Barzman DH
Psychiatr Q; 2013 Dec; 84(4):407-15. PubMed ID: 23443759
[TBL] [Abstract][Full Text] [Related]
37. Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands.
Hodgkins P; Sasané R; Meijer WM
Clin Ther; 2011 Feb; 33(2):188-203. PubMed ID: 21497704
[TBL] [Abstract][Full Text] [Related]
38. alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data.
Arnsten AF; Scahill L; Findling RL
J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):393-406. PubMed ID: 17822336
[TBL] [Abstract][Full Text] [Related]
39. Clinical review: evidence-based diagnosis and treatment of ADHD in children.
Nair J; Ehimare U; Beitman BD; Nair SS; Lavin A
Mo Med; 2006; 103(6):617-21. PubMed ID: 17256270
[TBL] [Abstract][Full Text] [Related]
40. Advances in alternative pharmacotherapy of ADHD.
Pityaratstian N
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S357-62. PubMed ID: 16623055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
